The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Liver resection and transplantation for intrahepatic cholangiocarcinoma
Open accessAbstract
The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although several advances have been made in the past decades to better understand this complex malignancy and to develop new treatment strategies, the prognosis of iCCA remains dismal. Liver resection (LR) is the mainstay of treatment but only a minority of patients are amenable to surgery. In most cases, patients with iCCA will require a major hepatectomy for complete resection of the tumour. This may be contraindicated or increase the surgical burden in patients with chronic liver disease and small remnant liver volume. Lymphadenectomy with a minimal harvest of 6 lymph nodes is considered adequate, as microscopic nodal metastases have been shown in more than 40% of patients. Current 5-year overall survival following LR is in the range of 25%-40%. For locally advanced disease not amenable to upfront LR, neoadjuvant locoregional therapies may be used with the aim of converting these patients to resectability or even to transplantation in well-selected cases. Recent studies have shown that liver transplantation (LT) might be a treatment option for patients with unresectable very-early iCCA (i.e. ≤2 cm), with survival outcomes comparable to those of hepatocellular carcinoma. In patients with unresectable, advanced tumours, confined to the liver who achieve sustained response to neoadjuvant treatment, LT may be considered an option within prospective protocols. The role of adjuvant therapies in iCCA is still under debate. Herein, we review the recent advances in the surgical treatment of iCCA and examine its correlation with locoregional therapies, adjuvant and neo-adjuvant strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Self-citationCholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Genomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Primrose, J. N., Fox, R. P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., Anthony, A., Corrie, P., Falk, S., Finch-Jones, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30915-x · Cited by 1,273
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Endo, I., Gonen, M., Yopp, A. C., Dalal, K. M., Zhou, Q., Klimstra, D., D'Angelica, M., DeMatteo, R. P., Fong, Y., Schwartz, L., et al. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318176c4d3 · Cited by 865
Mavros, M. N., Economopoulos, K. P., Alexiou, V. G., & Pawlik, T. M. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.5137 · Cited by 808
Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing
Ciria, R., Cherqui, D., Geller, D. A., Briceno, J., & Wakabayashi, G. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001413 · Cited by 747
de Jong, M. C., Nathan, H., Sotiropoulos, G. C., Paul, A., Alexandrescu, S., Marques, H., Pulitano, C., Barroso, E., Clary, B. M., Aldrighetti, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6519 · Cited by 729
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Javle, M., Lowery, M., Shroff, R. T., Weiss, K. H., Springfeld, C., Borad, M. J., Ramanathan, R. K., Goyal, L., Sadeghi, S., Macarulla, T., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.5009 · Cited by 693
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Bertuccio, P., Malvezzi, M., Carioli, G., Hashim, D., Boffetta, P., El-Serag, H. B., La Vecchia, C., & Negri, E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.013 · Cited by 648
Edeline, J., Benabdelghani, M., Bertaut, A., Watelet, J., Hammel, P., Joly, J.-P., Boudjema, K., Fartoux, L., Bouhier-Leporrier, K., Jouve, J.-L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.00050 · Cited by 541
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
Meyer, C. G., Penn, I., & James, L. (2000) · Transplantation · doi:10.1097/00007890-200004270-00019 · Cited by 502
Intrahepatic Cholangiocarcinoma: expert consensus statement
Weber, S. M., Ribero, D., O'Reilly, E. M., Kokudo, N., Miyazaki, M., & Pawlik, T. M. (2015) · HPB · doi:10.1111/hpb.12441 · Cited by 472
Liver Transplantation for Malignant Disease: Results in 93 Consecutive Patients
OʼGRADY, J. G., POLSON, R. J., ROLLES, K., CALNE, R. Y., & WILLIAMS, R. (1988) · Annals of Surgery · doi:10.1097/00000658-198804000-00002 · Cited by 446
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
Shroff, R. T., Kennedy, E. B., Bachini, M., Bekaii-Saab, T., Crane, C., Edeline, J., El-Khoueiry, A., Feng, M., Katz, M. H. G., Primrose, J., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02178 · Cited by 445
Sapisochin, G., Facciuto, M., Rubbia‐Brandt, L., Marti, J., Mehta, N., Yao, F. Y., Vibert, E., Cherqui, D., Grant, D. R., Hernandez‐Alejandro, R., et al. (2016) · Hepatology · doi:10.1002/hep.28744 · Cited by 370
Self-citationMazzaferro, V., El-Rayes, B. F., Droz dit Busset, M., Cotsoglou, C., Harris, W. P., Damjanov, N., Masi, G., Rimassa, L., Personeni, N., Braiteh, F., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0334-0 · Cited by 365
Self-citationEdeline, J., Touchefeu, Y., Guiu, B., Farge, O., Tougeron, D., Baumgaertner, I., Ayav, A., Campillo-Gimenez, B., Beuzit, L., Pracht, M., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3702 · Cited by 306
Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108702.45715.81 · Cited by 304
Choi, S.-B., Kim, K.-S., Choi, J.-Y., Park, S.-W., Choi, J.-S., Lee, W.-J., & Chung, J.-B. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0631-1 · Cited by 304
Lunsford, K. E., Javle, M., Heyne, K., Shroff, R. T., Abdel-Wahab, R., Gupta, N., Mobley, C. M., Saharia, A., Victor, D. W., Nguyen, D. T., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30045-1 · Cited by 298
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., & Toledano, M. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.015 · Cited by 290
Spolverato, G., Kim, Y., Alexandrescu, S., Marques, H. P., Lamelas, J., Aldrighetti, L., Clark Gamblin, T., Maithel, S. K., Pulitano, C., Bauer, T. W., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4642-9 · Cited by 283
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
Le Roy, B., Gelli, M., Pittau, G., Allard, M. A., Pereira, B., Serji, B., Vibert, E., Castaing, D., Adam, R., Cherqui, D., et al. (2018) · Journal of British Surgery · doi:10.1002/bjs.10641 · Cited by 256
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
Zhang, X. F., Beal, E. W., Bagante, F., Chakedis, J., Weiss, M., Popescu, I., Marques, H. P., Aldrighetti, L., Maithel, S. K., Pulitano, C., et al. (2018) · Journal of British Surgery · doi:10.1002/bjs.10676 · Cited by 250
Lowery, M. A., Burris, H. A., Janku, F., Shroff, R. T., Cleary, J. M., Azad, N. S., Goyal, L., Maher, E. A., Gore, L., Hollebecque, A., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30189-x · Cited by 224
International consensus statement on robotic hepatectomy surgery in 2018
Liu, R., Wakabayashi, G., Kim, H.-J., Choi, G.-H., Yiengpruksawan, A., Fong, Y., He, J., Boggi, U., Troisi, R. I., Efanov, M., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i12.1432 · Cited by 222
Shimoda, M., Farmer, D. G., Colquhoun, S. D., Rosove, M., Ghobrial, M. R., Yersiz, H., Chen, P., & Busuttil, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.29419 · Cited by 220
Goodman, Z. D. (2007) · Modern Pathology · doi:10.1038/modpathol.3800682 · Cited by 217
Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study
Tan, J. C. C., Coburn, N. G., Baxter, N. N., Kiss, A., & Law, C. H. L. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9627-x · Cited by 213
Hong, J. C. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.116 · Cited by 196
Sapisochin, G., de Lope, C. R., Gastaca, M., de Urbina, J. O., López-Andujar, R., Palacios, F., Ramos, E., Fabregat, J., Castroagudín, J. F., Varo, E., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000494 · Cited by 185
Self-citationBoehm, L. M., Jayakrishnan, T. T., Miura, J. T., Zacharias, A. J., Johnston, F. M., Turaga, K. K., & Gamblin, T. C. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23781 · Cited by 181
Wu, L., Tsilimigras, D. I., Paredes, A. Z., Mehta, R., Hyer, J. M., Merath, K., Sahara, K., Bagante, F., Beal, E. W., Shen, F., et al. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-04966-4 · Cited by 180
Kato, A., Shimizu, H., Ohtsuka, M., Yoshidome, H., Yoshitomi, H., Furukawa, K., Takeuchi, D., Takayashiki, T., Kimura, F., & Miyazaki, M. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2312-8 · Cited by 176
Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype
Jain, A., Borad, M. J., Kelley, R. K., Wang, Y., Abdel-Wahab, R., Meric-Bernstam, F., Baggerly, K. A., Kaseb, A. O., Al-shamsi, H. O., Ahn, D. H., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00080 · Cited by 173
Biliary tract cancer incidence and trends in the United States by demographic group, 1999‐2013
Van Dyke, A. L., Shiels, M. S., Jones, G. S., Pfeiffer, R. M., Petrick, J. L., Beebe‐Dimmer, J. L., & Koshiol, J. (2019) · Cancer · doi:10.1002/cncr.31942 · Cited by 170
Role of liver transplantation in the treatment of unresectable liver cancer
Pichlmayr, R., Weimann, A., Oldhafer, K. J., Schlitt, H. J., Klempnauer, J., Bornscheuer, A., Chavan, A., Schmoll, E., Lang, H., Tusch, G., et al. (1995) · World Journal of Surgery · doi:10.1007/bf00299775 · Cited by 166
Is liver transplantation indicated for cholangiocarcinoma?
Goldstein, R. M., Stone, M., Tillery, G. W., Senzer, N., Levy, M., Husberg, B. S., Gonwa, T., & Klintmalm, G. (1993) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80696-8 · Cited by 159
Is liver transplantation indicated for cholangiocarcinoma?
Jeyarajah, D. R., & Klintmalm, G. B. (1998) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/pl00009950 · Cited by 158
Lamarca, Á., Barriuso, J., Chander, A., McNamara, M. G., Hubner, R. A., O'Reilly, D. A., Manoharan, P., & Valle, J. W. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.038 · Cited by 152
Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experience
Ghali, P., Marotta, P. J., Yoshida, E. M., Bain, V. G., Marleau, D., Peltekian, K. M., Metrakos, P. P., & Deschênes, M. (2005) · Liver Transplantation · doi:10.1002/lt.20512 · Cited by 145
Bertuccio, P., Bosetti, C., Levi, F., Decarli, A., Negri, E., & Vecchia, C. L. (2013) · Annals of Oncology · doi:10.1093/annonc/mds652 · Cited by 135
Vilchez, V., Shah, M. B., Daily, M. F., Peña, L., Tzeng, C.-W. D., Davenport, D. L., Hosein, P. J., Gedaly, R., & Maynard, E. C. (2016) · HPB · doi:10.1016/j.hpb.2015.10.001 · Cited by 104
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany
von Hahn, T., Ciesek, S., Wegener, G., Plentz, R. R., Weismüller, T. J., Wedemeyer, H., Manns, M. P., Greten, T. F., & Malek, N. P. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.589472 · Cited by 100
Abou‐Alfa, G. K., Macarulla, T. M., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., Cleary, J. M., Catenacci, D. V. T., Borad, M. J., Bridgewater, J. A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz394.027 · Cited by 90
Glantzounis, G. K., Paliouras, A., Stylianidi, M. C., Milionis, H. J., Tzimas, P. G., Roukos, D. H., Pentheroudakis, G. E., & Felekouras, E. S. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.11.022 · Cited by 88
Si, A., Li, J., Yang, Z., Xia, Y., Yang, T., Lei, Z., Cheng, Z., Pawlik, T. M., Lau, W. Y., & Shen, F. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07260-8 · Cited by 88
Reames, B. N., Ejaz, A. M., Koerkamp, B. G., Alexandrescu, S. T., Marques, H. P., Aldrighetti, L. A., Maithel, S. K., Pulitanò, C., Bauer, T. W., Shen, F., et al. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24633 · Cited by 81
Altekruse, S. F., Petrick, J. L., Rolin, A. I., Cucinelli, J. E., Zou, Z., Tatalovich, Z., & McGlynn, K. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120574 · Cited by 79
Serenari, M., Zanello, M., Schadde, E., Toschi, E., Ratti, F., Gringeri, E., Masetti, M., Cillo, U., Aldrighetti, L. A., Jovine, E., et al. (2016) · HPB · doi:10.1016/j.hpb.2016.02.003 · Cited by 73
Self-citationDiagnostic and Prognostic Role of 18‐FDG PET/CT in the Management of Resectable Biliary Tract Cancer
Wing, K., Cheung, T. T., She, W. H., Chok, K., Chan, A. C. Y., Dai, W. C., Chiu, K. W.-H., & Lo, C. M. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4192-3 · Cited by 54
Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants
Vallin, M., Stürm, N., Lamblin, G., Guillaud, O., Hilleret, M., Hervieu, V., Joubert, J., Abergel, A., Leroy, V., Boillot, O., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12108 · Cited by 41
Hammad, A. Y., Berger, N. G., Eastwood, D. C., Tsai, S., Turaga, K. K., Christian, K. K., Johnston, F. M., Pawlik, T. M., & Gamblin, T. C. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5560-1 · Cited by 32
Lamberti, D., Cristinziano, G., Porru, M., Leonetti, C., Egan, J. B., Shi, C., Buglioni, S., Amoreo, C. A., Castellani, L., Borad, M. J., et al. (2018) · Hepatology · doi:10.1002/hep.30127 · Cited by 30
de Santibañes, M., Boccalatte, L. A., & de Santibáñes, E. (2016) · Updates in Surgery · doi:10.1007/s13304-016-0401-0 · Cited by 28
Jaklitsch, M., & Petrowsky, H. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.03.06 · Cited by 25
Cited by
Valle, J. W., Kelley, R. K., Nervi, B., Oh, D.-Y., & Zhu, A. X. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00153-7 · Cited by 1,043
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Alvaro, D., Gores, G. J., Walicki, J., Hassan, C., Sapisochin, G., Komuta, M., Forner, A., Valle, J. W., Laghi, A., Ilyas, S. I., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.010 · Cited by 344
Self-citation
Metadata
- Authors
- Mazzaferro, V., Gorgen, A., Roayaie, S., Droz dit Busset, M., & Sapisochin, G.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 72
- Issue
- 2
- Pages
- 364-377
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2999959056
- Cited by
- 355
- References
- 61
- FWCI
- 36.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.